[go: up one dir, main page]

DE69714579D1 - Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)-piperidin-1-yl)-2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten - Google Patents

Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)-piperidin-1-yl)-2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten

Info

Publication number
DE69714579D1
DE69714579D1 DE69714579T DE69714579T DE69714579D1 DE 69714579 D1 DE69714579 D1 DE 69714579D1 DE 69714579 T DE69714579 T DE 69714579T DE 69714579 T DE69714579 T DE 69714579T DE 69714579 D1 DE69714579 D1 DE 69714579D1
Authority
DE
Germany
Prior art keywords
benzamides
benzimidazol
piperidin
aryl
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69714579T
Other languages
English (en)
Other versions
DE69714579T2 (de
Inventor
George Daniel Maynard
John Michael Kane
Elizabeth Mary Kudlacz
Christopher Robin Dalton
Braulio Santiago
Larry Don Bratton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/778,996 external-priority patent/US5922737A/en
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69714579D1 publication Critical patent/DE69714579D1/de
Application granted granted Critical
Publication of DE69714579T2 publication Critical patent/DE69714579T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69714579T 1996-02-21 1997-01-29 Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)-piperidin-1-yl)-2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten Expired - Fee Related DE69714579T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60421696A 1996-02-21 1996-02-21
US08/778,996 US5922737A (en) 1996-02-21 1997-01-06 Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
PCT/US1997/001571 WO1997030989A1 (en) 1996-02-21 1997-01-29 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases

Publications (2)

Publication Number Publication Date
DE69714579D1 true DE69714579D1 (de) 2002-09-12
DE69714579T2 DE69714579T2 (de) 2003-04-10

Family

ID=27084615

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69714579T Expired - Fee Related DE69714579T2 (de) 1996-02-21 1997-01-29 Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)-piperidin-1-yl)-2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten

Country Status (20)

Country Link
EP (1) EP0888336B1 (de)
JP (1) JP2001504798A (de)
KR (1) KR19990087131A (de)
CN (1) CN1115341C (de)
AR (1) AR005896A1 (de)
AT (1) ATE221882T1 (de)
AU (1) AU710488B2 (de)
BR (1) BR9707652A (de)
CA (1) CA2247105C (de)
DE (1) DE69714579T2 (de)
DK (1) DK0888336T3 (de)
ES (1) ES2176687T3 (de)
HK (1) HK1019734A1 (de)
HU (1) HUP9901030A3 (de)
IL (1) IL125578A (de)
NO (1) NO983830L (de)
NZ (1) NZ330908A (de)
PT (1) PT888336E (de)
TW (1) TW562804B (de)
WO (1) WO1997030989A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
GB0315203D0 (en) * 2003-06-28 2003-08-06 Celltech R&D Ltd Chemical compounds
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
ATE177095T1 (de) * 1994-08-25 1999-03-15 Merrell Pharma Inc Substituierte piperidine für die behandlung von allergischen krankheiten

Also Published As

Publication number Publication date
CA2247105C (en) 2002-05-14
HUP9901030A2 (hu) 1999-07-28
CN1115341C (zh) 2003-07-23
CA2247105A1 (en) 1997-08-28
ES2176687T3 (es) 2002-12-01
IL125578A0 (en) 1999-03-12
IL125578A (en) 2002-09-12
DK0888336T3 (da) 2002-12-02
TW562804B (en) 2003-11-21
PT888336E (pt) 2002-12-31
AU710488B2 (en) 1999-09-23
JP2001504798A (ja) 2001-04-10
BR9707652A (pt) 1999-07-27
CN1211246A (zh) 1999-03-17
ATE221882T1 (de) 2002-08-15
AR005896A1 (es) 1999-07-21
AU2251997A (en) 1997-09-10
NO983830L (no) 1998-10-20
WO1997030989A1 (en) 1997-08-28
KR19990087131A (ko) 1999-12-15
NZ330908A (en) 2001-04-27
HK1019734A1 (en) 2000-02-25
EP0888336B1 (de) 2002-08-07
EP0888336A1 (de) 1999-01-07
DE69714579T2 (de) 2003-04-10
HUP9901030A3 (en) 2002-01-28
NO983830D0 (no) 1998-08-20

Similar Documents

Publication Publication Date Title
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
ATE297917T1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60104791D1 (de) Cyclobutendion-Derivate zur Behandlung von Artherosclerose
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE69714579D1 (de) Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)-piperidin-1-yl)-2(aryl)butyl)benzamide zur behandlung von allergischen krankheiten
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
DE69924284D1 (de) Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten
DE69731620D1 (de) Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60020833D1 (de) Melatonin zur behandlung von paralysen ausgelöst durch hirnschlag
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee